Biostax Corp (BTAX)

[locicat1]

As with the website these recently released statements are patently misleading.There have been NO Phase 2 studies performed under the direct control (IND) of the FDA for either IMUN or Cytocom specifically regarding any of the indications so indicated. Thus, Phase 3-ready is not yet appropriately established under FDA regulatory parameters for either IMUN or Cytocom.